摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-oxoaspidofractinine | 1179463-11-6

中文名称
——
中文别名
——
英文名称
5-oxoaspidofractinine
英文别名
(9R,21S)-2,12-diazahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3,5,7-trien-11-one
5-oxoaspidofractinine化学式
CAS
1179463-11-6
化学式
C19H22N2O
mdl
——
分子量
294.396
InChiKey
CGIRWPLJSHXIOH-MKCYZYCBSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.5
  • 重原子数:
    22
  • 可旋转键数:
    0
  • 环数:
    7.0
  • sp3杂化的碳原子比例:
    0.63
  • 拓扑面积:
    32.3
  • 氢给体数:
    1
  • 氢受体数:
    2

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    5-oxoaspidofractinine 在 lithium aluminium tetrahydride 、 、 sodium hydroxide 作用下, 以 四氢呋喃乙醚 为溶剂, 反应 2.0h, 以70%的产率得到aspidofractinine
    参考文献:
    名称:
    (+)-Aspidofractinine的立体选择性合成
    摘要:
    我们描述了(+)-aspidofractinine的合成,这是自然的kopsane家族生物碱的对映异构体。合成的关键特征包括在手性支架上将立体特异性氰酸酯重排成异氰酸酯,闭环的烯烃复分解以裂解手性助剂,以及化学选择性的环丙烷化以将季碳原子引入Aspidofractinine的7位。
    DOI:
    10.1021/jo9009497
  • 作为产物:
    描述:
    在 Raney 2800 nickel 作用下, 以 异丙醇 为溶剂, 反应 8.0h, 以67%的产率得到5-oxoaspidofractinine
    参考文献:
    名称:
    (+)-Aspidofractinine的立体选择性合成
    摘要:
    我们描述了(+)-aspidofractinine的合成,这是自然的kopsane家族生物碱的对映异构体。合成的关键特征包括在手性支架上将立体特异性氰酸酯重排成异氰酸酯,闭环的烯烃复分解以裂解手性助剂,以及化学选择性的环丙烷化以将季碳原子引入Aspidofractinine的7位。
    DOI:
    10.1021/jo9009497
点击查看最新优质反应信息

文献信息

  • Stereoselective Synthesis of (+)-Aspidofractinine
    作者:David Gagnon、Claude Spino
    DOI:10.1021/jo9009497
    日期:2009.8.21
    We describe the synthesis of (+)-aspidofractinine, the enantiomer of a naturally occurring alkaloid of the kopsane family. Key features of the synthesis include a stereospecific cyanate to isocyanate rearrangement on a chiral scaffold, a ring-closing alkene metathesis to cleave the chiral auxiliary, and a chemoselective cyclopropanation to introduce the quaternary carbon at position 7 of aspidofractinine
    我们描述了(+)-aspidofractinine的合成,这是自然的kopsane家族生物碱的对映异构体。合成的关键特征包括在手性支架上将立体特异性氰酸酯重排成异氰酸酯,闭环的烯烃复分解以裂解手性助剂,以及化学选择性的环丙烷化以将季碳原子引入Aspidofractinine的7位。
查看更多

同类化合物

蕊木宁F 蕊木宁 柯蒲木酮碱 夾竹桃鹼 (3aR,5R,5aR,10bR,13aS)-6-甲酰基-2,3,4,5,11,12-六氢-6H,13ah-3a,5a-乙桥-1H-吲哚嗪并[8,1-cd]咔唑-5-羧酸甲酯 (2a,3b,5a,6a,7a,20S)-6,7-环氧-20-羟基-白坚木替宁-3-羧酸甲酯 (2R,5S)-6alpha,7alpha-环氧白坚木替宁-3beta-羧酸甲酯 (2R,5R)-6,7-二去氢白坚木替宁-3beta-羧酸甲酯 16-epi-19-oxokopsinine methyl carbamate (+/-)-16-epi-19-R-mesyloxykopsinine 16-epi-19-oxokopsinine (+/-)-16-epi-19-R-hydroxykopsinine (-)-Norpleiomutine 16,17-Didehydro-5-oxo-18-(phenylsulfonyl)aspidofractinine N(1)-methyl-14,15-didehydroaspidofractinine Aspidofractinine-3-carboxylic acid, methyl ester, (2alpha,3beta,5alpha)- Methyl 1-formyl-17-methoxyaspidofractinine-21-carboxylate methyl (1R,9R,16R,18R,21S)-2,12-diazahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3,5,7,14-tetraene-18-carboxylate N(a),3β-Dimethoxycarbonyl-aspidofraktinin (+/-)-aspidofractinine aspidofractinin-4(or 20)-one 17-oxoaspidofractinine (+/-)-N-methyl-aspidofractinine Kopsinylalkohol aspidofractinine N1-acetylcopsinine methyl (1S,2R,4S,9R,17R,18R,22R)-3-oxa-6,16-diazaheptacyclo[15.2.2.11,6.02,4.09,17.010,15.09,22]docosa-10,12,14-triene-18-carboxylate methyl (1R,9R,16S,18R,21S)-6-[(15R,17R,19S)-15-(1-hydroxyethyl)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18)-tetraen-17-yl]-2,12-diazahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3(8),4,6-triene-18-carboxylate 5-oxoaspidofractinine methyl (1S,9R,16R,18R,21S)-2-acetyl-2,12-diazahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3,5,7-triene-18-carboxylate methyl (1S,9R,16S,18R,21S)-2-acetyl-2,12-diazahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3,5,7-triene-18-carboxylate (1S,9S,16R,18S,21S)-2-methoxycarbonyl-2,12-diazahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3,5,7-triene-18-carboxylic acid (1S,9R,16R,18S,21S)-2-methoxycarbonyl-2,12-diazahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3,5,7-triene-18-carboxylic acid methyl (1R,9R,16S,18S,21R)-2-formyl-4-methoxy-2,12-diazahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3(8),4,6-triene-18-carboxylate methyl (1S,9R,16R,18S,21S)-11-oxo-2,12-diazahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3,5,7-triene-18-carboxylate methyl (1S,9R,16R,18S,21S)-12-methyl-2-aza-12-azoniahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3,5,7-triene-18-carboxylate methyl (1S,9S,16S,18S,21S)-12-methyl-2-aza-12-azoniahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3,5,7-triene-18-carboxylate dimethyl (1S,9R,16R,18S,21S)-2,12-diazahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3,5,7-triene-2,18-dicarboxylate methyl (1S,9R,16R,18R,21S)-12-ethyl-2-aza-12-azoniahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3,5,7-triene-18-carboxylate methyl (1S,9R,16R,18S,21S)-2,12-diazahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3,5,7-triene-18-carboxylate methyl (1R,4R,12R,13S,16S)-17-oxo-5,14-diazahexacyclo[12.4.3.01,13.04,12.06,11.012,16]henicosa-6,8,10-triene-4-carboxylate methyl (1R,4R,12R,13S,16R)-17-oxo-5,14-diazahexacyclo[12.4.3.01,13.04,12.06,11.012,16]henicosa-6,8,10-triene-4-carboxylate methyl (1R,9R,12S,16R,18R,21R)-12-methyl-2-aza-12-azoniahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3,5,7-triene-18-carboxylate methyl (1S,9R,16S,18S,21R)-2-formyl-4-methoxy-2,12-diazahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3(8),4,6-triene-18-carboxylate Kopsan methyl (1S,9S,16S,18R,21R)-2-acetyl-12-methyl-2-aza-12-azoniahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3,5,7-triene-18-carboxylate dimethyl (1S,9R,16S,18S,21S)-2,12-diazahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3,5,7-triene-2,18-dicarboxylate methyl (1S,9S,16S,18S,21R)-2-formyl-4-methoxy-2,12-diazahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3(8),4,6-triene-18-carboxylate methyl (1S,9R,16S,18R,21S)-12-methyl-2-aza-12-azoniahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3,5,7-triene-18-carboxylate methyl (1R,9S,16R,18R,21S)-2,12-diazahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3,5,7-triene-18-carboxylate